Scott Ogg
Geschäftsführer bei ARMO BIOSCIENCES INC
Aktive Positionen von Scott Ogg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARMO BIOSCIENCES INC | Geschäftsführer | 01.05.2013 | - |
Karriereverlauf von Scott Ogg
Ehemalige bekannte Positionen von Scott Ogg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2011 | 01.04.2013 |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Corporate Officer/Principal | 13.08.2009 | 01.01.2011 |
Gilead Sciences International Ltd.
 Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Corporate Officer/Principal | - | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - | - |
Ausbildung von Scott Ogg
| Albion College | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| EXELIXIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
Gilead Sciences International Ltd.
Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
